NCT05084560View on ClinicalTrials.gov

Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug

PHASE1TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

May 22, 2023

Study Completion Date

May 22, 2023

Conditions
Filariasis, LymphaticOnchocerciasis
Interventions
DRUG

AWZ1066S

Candidate drug to treat lymphatic filariasis by targeting Wolbachia endosymbiont

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Liverpool University Hospitals NHS Foundation Trust, Liverpool

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

collaborator

Covance

INDUSTRY

collaborator

Subiaco Associates Limited

UNKNOWN

collaborator

Sylexis Limited

UNKNOWN

collaborator

Eisai Limited

INDUSTRY

lead

Liverpool School of Tropical Medicine

OTHER